Free Trial
NASDAQ:PETS

PetMed Express (PETS) Stock Price, News & Analysis

$3.50
-0.28 (-7.41%)
(As of 09/20/2024 ET)

About PetMed Express Stock (NASDAQ:PETS)

Key Stats

Today's Range
$3.50
$3.76
50-Day Range
$2.94
$4.04
52-Week Range
$2.90
$11.33
Volume
441,977 shs
Average Volume
176,083 shs
Market Capitalization
$72.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Reduce

Company Overview

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 17th Percentile

PetMed Express scored higher than 17% of companies evaluated by MarketBeat, and ranked 920th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PetMed Express has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    PetMed Express has only been the subject of 1 research reports in the past 90 days.

  • Read more about PetMed Express' stock forecast and price target.
  • Earnings Growth

    Earnings for PetMed Express are expected to grow by 12.50% in the coming year, from $0.08 to $0.09 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PetMed Express is -8.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PetMed Express is -8.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    PetMed Express has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about PetMed Express' valuation and earnings.
  • Percentage of Shares Shorted

    10.38% of the float of PetMed Express has been sold short.
  • Short Interest Ratio / Days to Cover

    PetMed Express has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in PetMed Express has recently increased by 16.76%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    PetMed Express does not currently pay a dividend.

  • Dividend Growth

    PetMed Express does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.38% of the float of PetMed Express has been sold short.
  • Short Interest Ratio / Days to Cover

    PetMed Express has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in PetMed Express has recently increased by 16.76%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    PetMed Express has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for PetMed Express this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for PETS on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added PetMed Express to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PetMed Express insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,917.00 in company stock.

  • Percentage Held by Insiders

    Only 1.10% of the stock of PetMed Express is held by insiders.

  • Percentage Held by Institutions

    73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about PetMed Express' insider trading history.
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Stock News Headlines

How the US Will Win the Great Lithium Race
China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill.
PetMed Express Names Robyn D'Elia Chief Financial Officer
Morgan Stanley Reaffirms Their Sell Rating on Petmed Express (PETS)
See More Headlines

PETS Stock Analysis - Frequently Asked Questions

PetMed Express' stock was trading at $7.56 at the beginning of 2024. Since then, PETS stock has decreased by 53.7% and is now trading at $3.50.
View the best growth stocks for 2024 here
.

PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings data on Tuesday, August, 6th. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.30. The company had revenue of $67.95 million for the quarter, compared to the consensus estimate of $77.52 million. PetMed Express had a negative net margin of 1.24% and a negative trailing twelve-month return on equity of 3.44%.

Top institutional investors of PetMed Express include Renaissance Technologies LLC (6.14%), Federated Hermes Inc. (2.94%), AQR Capital Management LLC (2.87%) and Dimensional Fund Advisors LP (1.18%). Insiders that own company stock include Mathew N Hulett, Gian Fulgoni, Jacqueline Paula Smith and Christine Chambers.
View institutional ownership trends
.

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/06/2024
Today
9/20/2024
Next Earnings (Estimated)
11/04/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Retailers
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
287
Year Founded
1996

Price Target and Rating

Average Stock Price Target
$3.50
High Stock Price Target
$3.50
Low Stock Price Target
$3.50
Potential Upside/Downside
-4.6%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$-7,460,000.00
Pretax Margin
-0.05%

Debt

Sales & Book Value

Annual Sales
$281.06 million
Cash Flow
$0.02 per share
Book Value
$4.57 per share

Miscellaneous

Free Float
20,380,000
Market Cap
$75.60 million
Optionable
Optionable
Beta
0.71

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NASDAQ:PETS) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners